Modulating production of pneumococcal capsular polysaccharide

Details for Australian Patent Application No. 2001245795 (hide)

Owner The Children's Hospital of Philadelphia

Inventors Weiser, Jeffrey N

Agent Pizzeys

Pub. Number AU-B-2001245795

PCT Pub. Number WO01/68903

Priority 60189847 16.03.00 US

Filing date 16 March 2001

Wipo publication date 24 September 2001

Acceptance publication date 28 July 2005

International Classifications

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A01N 063/00 Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 039/09 Medicinal preparations containing antigens or antibodies - Streptococcus

A61K 049/00 Preparations for testing

C12N 001/00 Micro-organisms, e.g. protozoa

C12Q 001/04 Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

Event Publications

28 July 2005 Application Accepted

  Published as AU-B-2001245795

24 November 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001245796-EMISSION CONTROL DEVICE AND METHOD

2001245794-Lung treatment apparatus